The OMERACT MRI inflammatory arthritis group: Advances and future research priorities

Philip G. Conaghan, Paul Bird, Fiona McQueen, Charles Peterfy, Pernille Bøyesen, Frédérique Gandjbakhch, Anne Duer-Jensen, Espen A. Haavardsholm, Bo Ejbjerg, Charlotte Wiell, Laura Coates, Kay Geert A. Hermann, Philip O'Connor, Marissa Lassere, Jane E. Freeston, Allen Anandarajah, Harry Genant, Paul Emery, Mikkel Østergaard

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group's effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS. The Journal of Rheumatology

    OriginalsprogEngelsk
    Sider (fra-til)1803-1805
    Antal sider3
    TidsskriftJournal of Rheumatology
    Vol/bind36
    Udgave nummer8
    DOI
    StatusUdgivet - 1 aug. 2009

    Fingeraftryk

    Udforsk hvilke forskningsemner 'The OMERACT MRI inflammatory arthritis group: Advances and future research priorities' indeholder.

    Citationsformater